Patient Overview & Treatment
An eight-year-old boy, whom we’ll call Ethan, was referred to care after his parents observed worsened agitation and new-onset hallucinations following treatment with guanfacine. His history included a diagnosis of Autism Spectrum Disorder, Level 2, with symptoms including repetitive vocalizations, self-stimulatory behaviors, and challenges with eye contact and nonverbal communication.
Initial genetic and metabolic testing (Genomind, organic acids, and kryptopyrrole) did not reveal significant abnormalities. However, a hair mineral analysis indicated elevated copper levels — above the 95th percentile. Unfortunately, Ethan was unable to tolerate blood draws, limiting further laboratory investigation.
Given the relationship between copper and zinc in neurochemical regulation, a trial of zinc supplementation was initiated (15 mg twice daily). Over the following six months, Ethan’s progress was remarkable. His parents and teachers noted reductions in agitation, improved emotional regulation, fewer vocalizations, and more consistent eye contact.
When clonidine was later added, his gains were further reinforced, leading to greater calm, engagement, and communication.
Functional Psychiatry Perspective: Behavioral Dysregulation in Children
This case highlights the powerful role of targeted nutrient support in children with autism and behavioral dysregulation. High copper levels can disrupt dopamine and norepinephrine balance, contributing to agitation, impulsivity, and mood instability. Restoring zinc balance supports more optimal neurotransmitter function and can improve core symptoms and overall regulation.
While not all children with autism present with copper-zinc imbalance, this case underscores the importance of looking beyond symptoms to uncover underlying biochemical contributors — and demonstrates how even simple interventions can yield profound results.
